Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Verhaeghe, J.
Right arrow Articles by Bouillon, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Verhaeghe, J.
Right arrow Articles by Bouillon, R.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes, Vol 39, Issue 4 477-482, Copyright © 1990 by American Diabetes Association


ARTICLES

Bone and mineral metabolism in BB rats with long-term diabetes. Decreased bone turnover and osteoporosis

J Verhaeghe, E van Herck, WJ Visser, AM Suiker, M Thomasset, TA Einhorn, E Faierman and R Bouillon
Laboratory for Experimental Medicine and Endocrinology, Katholieke Universiteit Leuven, Belgium.

The effect of long-term diabetes mellitus on bone and mineral metabolism was studied in BB rats. Diabetic rats were treated with 1 U of long-acting insulin every other day for 12 wk and compared with nondiabetic littermates. Urinary calcium excretion was increased greater than 10-fold, but serum total and diffusible calcium remained normal. Serum concentrations of both 1 alpha, 25-dihydroxyvitamin D3 and vitamin D-binding protein were significantly decreased in diabetic rats. The intestinal calbindin-D 9K concentration was decreased by nearly 50%, and active duodenal calcium absorption was totally abolished. Trabecular bone volume measured in the tibial metaphysis was decreased by 44%, and the osteoblast and osteoid surfaces were less than 10% of values observed in control rats, whereas the osteoclast surface was unchanged by diabetes. The daily bone formation (bone mineral apposition rate) measured by labeling twice with calcein was decreased by 86% in diabetic rats. The serum concentration of osteocalcin, a biochemical marker of osteoblast function, was similarly decreased (mean +/- SE 23 +/- 3 and 62 +/- 4 micrograms/L in diabetic [n = 15] and nondiabetic [n = 15] rats, respectively). Serum osteocalcin was significantly correlated with the serum concentration of insulinlike growth factor I (r = 0.89, P less than 0.001). Bone strength measured as the energy needed to fracture the femur was markedly decreased (5.3 +/- 1.4 and 8.4 +/- 1.3 N.m.degree in diabetic and nondiabetic rats, respectively; P less than 0.01). These histological, chemical, and biomechanical data clearly indicate that long-standing diabetes in BB rats results in severe low-turnover osteoporosis probably related to decreased osteoblast recruitment and/or function.
Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
K. Fulzele, D. J. DiGirolamo, Z. Liu, J. Xu, J. L. Messina, and T. L. Clemens
Disruption of the Insulin-like Growth Factor Type 1 Receptor in Osteoblasts Enhances Insulin Signaling and Action
J. Biol. Chem., August 31, 2007; 282(35): 25649 - 25658.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
R. Irwin, H. V. Lin, K. J. Motyl, and L. R. McCabe
Normal Bone Density Obtained in the Absence of Insulin Receptor Expression in Bone
Endocrinology, December 1, 2006; 147(12): 5760 - 5767.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
K. M. Thrailkill, C. K. Lumpkin Jr., R. C. Bunn, S. F. Kemp, and J. L. Fowlkes
Is insulin an anabolic agent in bone? Dissecting the diabetic bone for clues
Am J Physiol Endocrinol Metab, November 1, 2005; 289(5): E735 - E745.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
S. Botolin, M.-C. Faugere, H. Malluche, M. Orth, R. Meyer, and L. R. McCabe
Increased Bone Adiposity and Peroxisomal Proliferator-Activated Receptor-{gamma}2 Expression in Type I Diabetic Mice
Endocrinology, August 1, 2005; 146(8): 3622 - 3631.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
M. K Walti, M. B Zimmermann, T. Walczyk, G. A Spinas, and R. F Hurrell
Measurement of magnesium absorption and retention in type 2 diabetic patients with the use of stable isotopes
Am. J. Clinical Nutrition, September 1, 2003; 78(3): 448 - 453.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Zayzafoon, S. Botolin, and L. R. McCabe
p38 and Activating Transcription Factor-2 Involvement in Osteoblast Osmotic Response to Elevated Extracellular Glucose
J. Biol. Chem., September 27, 2002; 277(40): 37212 - 37218.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
D. Vanderschueren, L. Vandenput, S. Boonen, E. Van Herck, J. V. Swinnen, and R. Bouillon
An Aged Rat Model of Partial Androgen Deficiency: Prevention of Both Loss of Bone and Lean Body Mass by Low-Dose Androgen Replacement
Endocrinology, May 1, 2000; 141(5): 1642 - 1647.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
R. C. Pereira, F. Blanquaert, and E. Canalis
Cortisol Enhances the Expression of mac25/Insulin-Like Growth Factor-Binding Protein-Related Protein-1 in Cultured Osteoblasts
Endocrinology, January 1, 1999; 140(1): 228 - 232.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
D. Vanderschueren, E. Van Herck, J. Nijs, A. G. H. Ederveen, R. De Coster, and R. Bouillon
Aromatase Inhibition Impairs Skeletal Modeling and Decreases Bone Mineral Density in Growing Male Rats
Endocrinology, June 1, 1997; 138(6): 2301 - 2307.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 1990 by the American Diabetes Association.